PT1250133E - Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto - Google Patents

Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto

Info

Publication number
PT1250133E
PT1250133E PT01906672T PT01906672T PT1250133E PT 1250133 E PT1250133 E PT 1250133E PT 01906672 T PT01906672 T PT 01906672T PT 01906672 T PT01906672 T PT 01906672T PT 1250133 E PT1250133 E PT 1250133E
Authority
PT
Portugal
Prior art keywords
compositions
contact lenses
antialergic
properties suitable
ophthalmic properties
Prior art date
Application number
PT01906672T
Other languages
English (en)
Portuguese (pt)
Inventor
John M Yanni
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PT1250133E publication Critical patent/PT1250133E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT01906672T 2000-01-25 2001-01-24 Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto PT1250133E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17780400P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
PT1250133E true PT1250133E (pt) 2005-05-31

Family

ID=22650044

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01906672T PT1250133E (pt) 2000-01-25 2001-01-24 Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto

Country Status (10)

Country Link
US (1) US6375973B2 (cg-RX-API-DMAC7.html)
EP (1) EP1250133B1 (cg-RX-API-DMAC7.html)
JP (2) JP2003520813A (cg-RX-API-DMAC7.html)
AT (1) ATE291913T1 (cg-RX-API-DMAC7.html)
AU (1) AU776789B2 (cg-RX-API-DMAC7.html)
CA (1) CA2395866C (cg-RX-API-DMAC7.html)
DE (1) DE60109742T2 (cg-RX-API-DMAC7.html)
ES (1) ES2236180T3 (cg-RX-API-DMAC7.html)
PT (1) PT1250133E (cg-RX-API-DMAC7.html)
WO (1) WO2001054687A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
CA2597219C (en) * 2005-02-04 2014-04-15 Auburn University Contact drug delivery system
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US7947010B2 (en) * 2005-07-08 2011-05-24 Depuy Products, Inc. Composition and system for wound decontamination
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US20080138408A1 (en) 2006-11-13 2008-06-12 Siddharth Venkatesh Drug delivery system and method
SI2114367T1 (sl) * 2007-02-07 2016-01-29 Novartis Ag Formulacije olopatadina za topično nazalno dajanje
AU2011282252B2 (en) * 2010-07-21 2014-08-21 Alcon Research, Ltd. Pharmaceutical composition with enhanced solubility characteristics
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
CA2929074A1 (en) * 2013-10-31 2015-05-07 Nephron Pharmaceuticals Corporation Formulation of olopatadine
EP3037094A1 (en) 2014-12-23 2016-06-29 Poifa Warszawa SA Ophthalmic pharmaceutical composition
CN107875119B (zh) * 2017-11-22 2021-03-12 山东绅联药业有限公司 一种富马酸依美斯汀水性药物组合物及其制备方法
WO2025137749A1 (pt) * 2023-12-27 2025-07-03 Eurofarma Laboratórios S.A. Processo de solubilização de olopatadina e seu uso

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
JPS5879983A (ja) 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPH08770B2 (ja) * 1985-12-25 1996-01-10 千寿製薬株式会社 眼科用組成物
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
CA2132826C (en) 1992-05-06 1999-01-05 Masood Chowhan Use of borate-polyol complexes in ophthalmic compositions
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
JP3527256B2 (ja) * 1992-12-09 2004-05-17 ロート製薬株式会社 抗アレルギー点眼剤
US5668133A (en) 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
US5370744B1 (en) * 1993-08-27 1999-11-09 Alcon Lab Inc Process for cleaning and disinfecting contact lenses
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
BR9711406A (pt) * 1996-09-20 1999-08-17 Bausch & Lomb Sistema e m-todo para reumidifica-Æo de lentes de contato e alivio da secura dos olhos
ZA9811445B (en) * 1997-12-19 1999-08-16 Alcon Lab Inc Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
ES2203103T3 (es) * 1998-04-07 2004-04-01 Alcon Manufacturing Ltd. Composiciones oftalmicas gelificantes que contienen goma xantana.
JP3407654B2 (ja) * 1998-04-14 2003-05-19 ライオン株式会社 眼科用組成物
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions

Also Published As

Publication number Publication date
DE60109742T2 (de) 2005-08-18
DE60109742D1 (de) 2005-05-04
WO2001054687A1 (en) 2001-08-02
AU3455601A (en) 2001-08-07
EP1250133A1 (en) 2002-10-23
EP1250133B1 (en) 2005-03-30
US6375973B2 (en) 2002-04-23
US20010056093A1 (en) 2001-12-27
JP2011132259A (ja) 2011-07-07
ATE291913T1 (de) 2005-04-15
CA2395866C (en) 2009-10-13
AU776789B2 (en) 2004-09-23
ES2236180T3 (es) 2005-07-16
JP2003520813A (ja) 2003-07-08
CA2395866A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
PT1250133E (pt) Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto
FR2704327B1 (fr) Paire de lentilles ophtalmiques multifocales progressives.
DK1026533T3 (da) Progressive additionslinser med regressive overflader
BRPI0109443B1 (pt) hidrogel de silicone umectÁvel, lentes oftÁlmicas e mÉtodo de preparaÇço de um hidrogel de silicone.
DE60139390D1 (de) Binokulare linsensysteme
BR0113589A (pt) Lentes oftálmicas úteis na correção de astigmatismo e presbiopia
MXPA03004041A (es) Lentes oftalmicas sin union y metodos para su produccion.
BR0016386A (pt) Lentes oftálmicas multifocais birrefringentes refrativas hìbridas
NO981151D0 (no) Kontaktlinse med forhöyninger for öyelokk-kontakt
ECSP044862A (es) Pirenzepine ophthalmic gel
FR2803921B1 (fr) Jeu de deux lentilles ophtalmiques, gamme et procede pour constituer un tel jeu
AR031417A1 (es) Sistemas desinfectantes acuosos
NO20011396L (no) Öyebeskyttelse
AR034200A1 (es) Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
HK1046631A1 (zh) 含有酮替芬的眼药组合物
DE60119166D1 (de) Monomerzusammensetzung, daraus erhaltenes polymer und okularlinse
FR2803922B1 (fr) Lentille ophtalmique
DK1445641T3 (da) Okulære linser
ATE257371T1 (de) Augenspüllösung
SE0001925D0 (sv) Methods of obtaining ophthalmic lenses capable of reducing the aberrations of the eye
EA200300789A1 (ru) Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи
ECSP992838A (es) Lente de contacto multifocal progresiva adecuada para compensacion de la presbiopia
IT1307972B1 (it) Perfezionamento di astina di occhiali con estremita' dotata di mollaelasticizzante.
BR9603465A (pt) Simulador dinâmico do cristalino ocular
DK1250133T3 (da) Oftalmiske anti-allergiske præparater egnet til anvendelse med kontaktlinser